We are live on ! Find out more
OAG

Orbis Allan Gray Portfolio holdings

AUM $23.7B
1-Year Est. Return 65.43%
This Fund
S&P 500
This Quarter Est. Return
+0.33%
1 Year Est. Return
+65.43%
3 Year Est. Return
+132.45%
5 Year Est. Return
+177.59%
10 Year Est. Return
+818.17%
AUM
$13.9B
AUM Growth
-$853M
Cap. Flow
-$759M
Cap. Flow %
-5.47%
Top 10 Hldgs %
70.08%
Holding
61
New
4
Increased
19
Reduced
26
Closed
4

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$423M
2
SLB icon
SLB Ltd
SLB
+$211M
3
HWM icon
Howmet Aerospace
HWM
+$185M
4
WFC icon
Wells Fargo
WFC
+$122M
5
DG icon
Dollar General
DG
+$103M

Sector Composition

Rank Sector Weight
1 Communication Services 35.13%
2 Healthcare 21.81%
3 Industrials 11.31%
4 Energy 9.11%
5 Financials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVX icon
51
Chevron
CVX
$389B
$1.25M 0.01%
+10,031
New +$1.21M
MCK icon
52
McKesson
MCK
$98.6B
$1.24M 0.01%
+9,186
New +$1.15M
LILAK icon
53
Liberty Latin America Class C
LILAK
$1.51B
$1.16M 0.01%
78,765
MCD icon
54
McDonald's
MCD
$189B
$659K ﹤0.01%
3,175
SMFG icon
55
Sumitomo Mitsui Financial
SMFG
$167B
$587K ﹤0.01%
83,138
-4,572
-5% -$32.4K
AMRWW
56
DELISTED
Alta Mesa Resources Inc Warrant
AMRWW
$33K ﹤0.01%
4,649,574
TME icon
57
Tencent Music
TME
$14.5B
$1K ﹤0.01%
86
-383
-82% -$6.05K
BMY icon
58
Bristol-Myers Squibb
BMY
$127B
-656,994
Closed -$31.3M
DXC icon
59
DXC Technology
DXC
$1.62B
-19,678
Closed -$1.26M
HMC icon
60
Honda
HMC
$36.6B
-49,491
Closed -$1.34M
MRK icon
61
Merck
MRK
$324B
-292,953
Closed -$23.2M

Similar funds

Orbis Allan Gray's Q2 2019 Portfolio in Review

As of Q2 2019, Orbis Allan Gray held 61 positions worth $13.9B, down 5.8% from $14.7B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Orbis Allan Gray withdrew a net $759M in Q2 2019, closing 4 positions and reducing 26 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $31.3M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 35% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Orbis Allan Gray opened a new position in Alibaba worth $6.24M.

  • Orbis Allan Gray's largest Q2 2019 buy was Alibaba: 36,847 shares worth $6.24M.
  • Orbis Allan Gray added most to UnitedHealth in Q2 2019, an estimated $187M increase.
  • Orbis Allan Gray's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $423M.
  • Orbis Allan Gray fully exited Bristol-Myers Squibb in Q2 2019, selling an estimated $31.3M.
  • Orbis Allan Gray's ten largest holdings make up 70% of its $13.9B portfolio in Q2 2019.
  • Orbis Allan Gray opened 4 new positions and closed 4 in Q2 2019.
  • Orbis Allan Gray's portfolio value fell 5.8% quarter-over-quarter to $13.9B.

Based on Orbis Allan Gray's 13F filing for Q2 2019, filed 14 Aug 2019.